Table 1.
Variables | Patients with SARS-CoV-2
infection (n = 10,470) |
Patients without SARS-CoV-2
infection (n = 10,470) |
p-value |
---|---|---|---|
Demographics | |||
Age (years) | |||
<35 | 728 (6.8%) | 728 (6.8%) | 1.00 |
35–54 | 2333 (21.8%) | 2335 (21.8%) | 1.00 |
55–70 | 3857 (36.0%) | 3805 (35.6%) | 0.46 |
>70 | 3771 (35.3%) | 3823 (35.8%) | 0.46 |
Sex | |||
Men | 4918 (46.0%) | 4918 (46.0%) | 1.00 |
Women | 5773 (54.0%) | 5773 (54.0%) | 1.00 |
Race/ethnicity | |||
White | 7575 (70.9%) | 7575 (70.9%) | 1.00 |
Black | 1266 (11.8%) | 1266 (11.8%) | 1.00 |
Hispanic | 765 (7.2%) | 765 (7.2%) | 1.00 |
Asian | 56 (0.5%) | 56 (0.5%) | 1.00 |
Other | 1029 (9.6%) | 1029 (9.6%) | 1.00 |
Cardiovascular risk factors/diseases | |||
Hypertension | 8302 (77.7%) | 8127 (76.0%) | 0.004 |
Diabetes mellitus | 5666 (53.0%) | 4655 (43.5%) | <0.001 |
Hyperlipidemia | 6850 (64.0%) | 6268 (58.3%) | <0.001 |
Nicotine dependence/tobacco use | 2027 (19.0%) | 4077 (38.1%) | <0.001 |
Alcohol use or abuse | 661 (6.2%) | 1394 (13.0%) | <0.001 |
Atrial fibrillation | 2199 (20.6%) | 2846 (26.6%) | <0.001 |
Congestive heart failure | 2708 (25.3%) | 4083 (38.2%) | <0.001 |
Previous acute myocardial infarction | 727 (6.8%) | 919 (8.9%) | <0.001 |
Previous ischemic stroke | 500 (4.7%) | 601 (5.6%) | 0.002 |
Previous intracerebral hemorrhage | 56 (0.5%) | 74 (0.7%) | 0.11 |
Previous subarachnoid hemorrhage | 30 (0.3%) | 36 (0.3%) | 0.46 |
Previous unstable angina | 110 (1.0%) | 122 (1.1%) | 0.43 |
Events during reference hospitalization | |||
Respiratory failure | 7219 (67.5%) | 4996 (46.7%) | <0.001 |
Dyspnea | 3752 (35.1%) | 3405 (31.8%) | <0.001 |
Chest pain | 970 (9.1%) | 1375 (12.9%) | <0.001 |
Septic shock | 559 (5.2%) | 670 (6.3%) | 0.001 |
Intubation/mechanical ventilation | 683 (6.4%) | 633 (5.9%) | 0.15 |
Non-routine discharge (excluding death) | 8295 (77.6%) | 8656 (81.0%) | <0.0001 |
Expired in hospital | 293 (2.7%) | 468 (4.4%) | <0.0001 |
SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.